PubRank

Ursula Ravens

Author PubWeight™ 114.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial. Lancet 2012 5.00
2 A new approach to transcription factor screening for reprogramming of fibroblasts to cardiomyocyte-like cells. J Mol Cell Cardiol 2012 2.71
3 Enhanced sarcoplasmic reticulum Ca2+ leak and increased Na+-Ca2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation. Circulation 2012 2.58
4 The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management. Europace 2009 2.52
5 Calcium-handling abnormalities underlying atrial arrhythmogenesis and contractile dysfunction in dogs with congestive heart failure. Circ Arrhythm Electrophysiol 2008 2.37
6 Defective cardiac ryanodine receptor regulation during atrial fibrillation. Circulation 2005 2.15
7 Molecular determinants of altered Ca2+ handling in human chronic atrial fibrillation. Circulation 2006 2.00
8 Outcome parameters for trials in atrial fibrillation: executive summary. Eur Heart J 2007 1.90
9 Role of IKur in controlling action potential shape and contractility in the human atrium: influence of chronic atrial fibrillation. Circulation 2004 1.77
10 Functional modulation of the transient outward current Ito by KCNE beta-subunits and regional distribution in human non-failing and failing hearts. Cardiovasc Res 2006 1.62
11 Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease. Circ Res 2009 1.58
12 Decreased ATP-sensitive K(+) current density during chronic human atrial fibrillation. J Mol Cell Cardiol 2003 1.54
13 Electrophysiological properties of human mesenchymal stem cells. J Physiol 2003 1.53
14 Left-to-right atrial inward rectifier potassium current gradients in patients with paroxysmal versus chronic atrial fibrillation. Circ Arrhythm Electrophysiol 2010 1.49
15 Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association. Europace 2007 1.46
16 Expression and function of dipeptidyl-aminopeptidase-like protein 6 as a putative beta-subunit of human cardiac transient outward current encoded by Kv4.3. J Physiol 2005 1.43
17 Activation of human ether-a-go-go-related gene potassium channels by the diphenylurea 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643). Mol Pharmacol 2005 1.37
18 Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference. Europace 2011 1.35
19 Adult zebrafish heart as a model for human heart? An electrophysiological study. J Mol Cell Cardiol 2009 1.29
20 Update of the guidelines on sudden cardiac death of the European Society of Cardiology. Eur Heart J 2003 1.21
21 Epinephrine activates both Gs and Gi pathways, but norepinephrine activates only the Gs pathway through human beta2-adrenoceptors overexpressed in mouse heart. Mol Pharmacol 2004 1.21
22 Remodeling of cardiomyocyte ion channels in human atrial fibrillation. Basic Res Cardiol 2003 1.20
23 Ionic mechanisms limiting cardiac repolarization reserve in humans compared to dogs. J Physiol 2013 1.17
24 Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference. Europace 2013 1.16
25 Human inward rectifier potassium channels in chronic and postoperative atrial fibrillation. Cardiovasc Res 2002 1.15
26 Distinct contractile and molecular differences between two goat models of atrial dysfunction: AV block-induced atrial dilatation and atrial fibrillation. J Mol Cell Cardiol 2008 1.09
27 Specific beta(2)AR blocker ICI 118,551 actively decreases contraction through a G(i)-coupled form of the beta(2)AR in myocytes from failing human heart. Circulation 2002 1.07
28 Differential phosphorylation-dependent regulation of constitutively active and muscarinic receptor-activated IK,ACh channels in patients with chronic atrial fibrillation. Cardiovasc Res 2007 1.06
29 Cardiac mechano-electric feedback: past, present, and prospect. Prog Biophys Mol Biol 2003 1.06
30 Comparing the global mRNA expression profile of human atrial and ventricular myocardium with high-density oligonucleotide arrays. J Thorac Cardiovasc Surg 2005 1.05
31 Multiple potential molecular contributors to atrial hypocontractility caused by atrial tachycardia remodeling in dogs. Circ Arrhythm Electrophysiol 2010 1.05
32 Inotropy and L-type Ca2+ current, activated by beta1- and beta2-adrenoceptors, are differently controlled by phosphodiesterases 3 and 4 in rat heart. Br J Pharmacol 2009 1.02
33 Changes in I K, ACh single-channel activity with atrial tachycardia remodelling in canine atrial cardiomyocytes. Cardiovasc Res 2007 1.01
34 Early and comprehensive management of atrial fibrillation: proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'. Europace 2009 1.01
35 Biophysical characterization of the new human ether-a-go-go-related gene channel opener NS3623 [N-(4-bromo-2-(1H-tetrazol-5-yl)-phenyl)-N'-(3'-trifluoromethylphenyl)urea]. Mol Pharmacol 2006 1.01
36 Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'. Eur Heart J 2009 1.00
37 Molecular and functional expression of voltage-operated calcium channels during osteogenic differentiation of human mesenchymal stem cells. J Bone Miner Res 2005 0.98
38 Differentiation efficiency of induced pluripotent stem cells depends on the number of reprogramming factors. Stem Cells 2012 0.96
39 Contribution of Ca2+ influx to carbachol-induced detrusor contraction is different in human urinary bladder compared to pig and mouse. Eur J Pharmacol 2007 0.96
40 Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles. Eur Heart J 2009 0.96
41 Tissue slices from adult mammalian hearts as a model for pharmacological drug testing. Cell Physiol Biochem 2009 0.95
42 Catecholamines relax detrusor through beta 2-adrenoceptors in mouse and beta 3-adrenoceptors in man. J Pharmacol Exp Ther 2008 0.94
43 Tissue distribution of a human Ca v 1.2 alpha1 subunit splice variant with a 75 bp insertion. Cell Calcium 2005 0.94
44 Pharmacological evidence for altered src kinase regulation of I (Ca,L) in patients with chronic atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol 2007 0.94
45 Cholinergic and purinergic responses in isolated human detrusor in relation to age. J Urol 2005 0.94
46 Human electrophysiological and pharmacological properties of XEN-D0101: a novel atrial-selective Kv1.5/IKur inhibitor. J Cardiovasc Pharmacol 2013 0.93
47 The new antiarrhythmic drug vernakalant: ex vivo study of human atrial tissue from sinus rhythm and chronic atrial fibrillation. Cardiovasc Res 2013 0.93
48 Tachycardia-induced silencing of subcellular Ca2+ signaling in atrial myocytes. J Clin Invest 2014 0.93
49 Myocardial tissue slices: organotypic pseudo-2D models for cardiac research & development. Future Cardiol 2009 0.93
50 The impact of rapid atrial pacing on ADMA and endothelial NOS. Int J Cardiol 2010 0.92
51 5-Azacytidine induces changes in electrophysiological properties of human mesenchymal stem cells. Cell Res 2006 0.89
52 Pharmacodynamics of propiverine and three of its main metabolites on detrusor contraction. Br J Pharmacol 2005 0.88
53 Cardiostimulant and cardiodepressant effects through overexpressed human beta2-adrenoceptors in murine heart: regional differences and functional role of beta1-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 2003 0.88
54 A new toxin from the sea anemone Condylactis gigantea with effect on sodium channel inactivation. Toxicon 2006 0.88
55 Design and validation of a bioreactor for simulating the cardiac niche: a system incorporating cyclic stretch, electrical stimulation, and constant perfusion. Tissue Eng Part A 2012 0.88
56 Class I/B antiarrhythmic property of ranolazine, a novel antianginal agent, in dog and human cardiac preparations. Eur J Pharmacol 2011 0.88
57 Identification and characterization of G beta 3s2, a novel splice variant of the G-protein beta 3 subunit. Biochem J 2003 0.88
58 Inhibition of IK,ACh current may contribute to clinical efficacy of class I and class III antiarrhythmic drugs in patients with atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol 2009 0.87
59 Impaired vascular function in small resistance arteries of LOX-1 overexpressing mice on high-fat diet. Cardiovasc Res 2009 0.87
60 Carvedilol blocks beta2- more than beta1-adrenoceptors in human heart. Cardiovasc Res 2005 0.87
61 PDE3, but not PDE4, reduces β₁ - and β₂-adrenoceptor-mediated inotropic and lusitropic effects in failing ventricle from metoprolol-treated patients. Br J Pharmacol 2013 0.87
62 Human atrial β(1L)-adrenoceptor but not β₃-adrenoceptor activation increases force and Ca(2+) current at physiological temperature. Br J Pharmacol 2011 0.86
63 Differentiation of chromaffin progenitor cells to dopaminergic neurons. Cell Transplant 2012 0.86
64 Beta adrenergic receptor-mediated atrial specific up-regulation of RGS5. Life Sci 2004 0.86
65 Interaction between autoantibodies against the beta1-adrenoceptor and isoprenaline in enhancing L-type Ca2+ current in rat ventricular myocytes. J Mol Cell Cardiol 2006 0.85
66 Differentiation induction of mouse embryonic stem cells into sinus node-like cells by suramin. Int J Cardiol 2009 0.85
67 Physiological antagonism between ventricular beta 1-adrenoceptors and alpha 1-adrenoceptors but no evidence for beta 2- and beta 3-adrenoceptor function in murine heart. Br J Pharmacol 2002 0.85
68 Cardiac tissue engineering. Transpl Immunol 2002 0.85
69 Propiverine and metabolites: differences in binding to muscarinic receptors and in functional models of detrusor contraction. Naunyn Schmiedebergs Arch Pharmacol 2006 0.85
70 Silencing the cardiac potassium channel Kv4.3 by RNA interference in a CHO expression system. Biochem Biophys Res Commun 2005 0.84
71 The transmembrane beta-subunits KCNE1, KCNE2, and DPP6 modify pharmacological effects of the antiarrhythmic agent tedisamil on the transient outward current Ito. Naunyn Schmiedebergs Arch Pharmacol 2009 0.84
72 An aqueous extract of the marine sponge Ectyoplasia ferox stimulates L-type Ca2+-current by direct interaction with the Cav1.2 subunit. Naunyn Schmiedebergs Arch Pharmacol 2004 0.83
73 Therapeutically relevant concentrations of neomycin selectively inhibit P-type Ca2+ channels in rat striatum. Eur J Pharmacol 2003 0.82
74 Risperidone-induced action potential prolongation is attenuated by increased repolarization reserve due to concomitant block of I(Ca,L). Naunyn Schmiedebergs Arch Pharmacol 2005 0.82
75 Altered expression of genes for Kir ion channels in dilated cardiomyopathy. Can J Physiol Pharmacol 2013 0.81
76 The effects of levosimendan on myocardial function in ropivacaine toxicity in isolated guinea pig heart preparations. Anesth Analg 2007 0.81
77 Impaired Na⁺-dependent regulation of acetylcholine-activated inward-rectifier K⁺ current modulates action potential rate dependence in patients with chronic atrial fibrillation. J Mol Cell Cardiol 2013 0.81
78 Anticholinergic effects of cis- and trans-isomers of two metabolites of propiverine. Naunyn Schmiedebergs Arch Pharmacol 2010 0.81
79 Cardiac tissue slices with prolonged survival for in vitro drug safety screening. J Pharmacol Toxicol Methods 2011 0.81
80 Electrophysiological profile of propiverine--relationship to cardiac risk. Naunyn Schmiedebergs Arch Pharmacol 2007 0.81
81 Mkk4 is a negative regulator of the transforming growth factor beta 1 signaling associated with atrial remodeling and arrhythmogenesis with age. J Am Heart Assoc 2014 0.81
82 β-Adrenoceptor-Mediated Relaxation of Carbachol-Pre-Contracted Mouse Detrusor. Urol Int 2015 0.80
83 Impaired glycosylation blocks DPP10 cell surface expression and alters the electrophysiology of Ito channel complex. Pflugers Arch 2010 0.80
84 N-glycosylation of the mammalian dipeptidyl aminopeptidase-like protein 10 (DPP10) regulates trafficking and interaction with Kv4 channels. Int J Biochem Cell Biol 2012 0.80
85 Novel pharmacological approaches for antiarrhythmic therapy. Naunyn Schmiedebergs Arch Pharmacol 2010 0.80
86 Cardiac sympathetic innervation and control of potassium channel function. J Mol Cell Cardiol 2003 0.79
87 Sphingosine-1-phosphate induces contraction of valvular interstitial cells from porcine aortic valves. Cardiovasc Res 2012 0.79
88 Signals from embryonic fibroblasts induce adult intestinal epithelial cells to form nestin-positive cells with proliferation and multilineage differentiation capacity in vitro. Stem Cells 2006 0.79
89 Juvenile pig detrusor: effects of propiverine and three of its metabolites. Eur J Pharmacol 2005 0.79
90 The muscarinic receptor antagonist propiverine exhibits α(1)-adrenoceptor antagonism in human prostate and porcine trigonum. World J Urol 2011 0.79
91 Effects of immunoglobulin G from patients with dilated cardiomyopathy on rat cardiomyocytes. Basic Clin Pharmacol Toxicol 2005 0.79
92 New approaches in the modulation of bladder smooth muscle cells on viable detrusor constructs. World J Urol 2006 0.78
93 Skeletal muscle stem cells propagated as myospheres display electrophysiological properties modulated by culture conditions. J Mol Cell Cardiol 2010 0.78
94 Effect of rilmakalim on detrusor contraction in the presence and absence of urothelium. Naunyn Schmiedebergs Arch Pharmacol 2005 0.78
95 Different responses to drugs against overactive bladder in detrusor muscle of pig, guinea pig and mouse. Eur J Pharmacol 2002 0.78
96 Attenuated response of L-type calcium current to nitric oxide in atrial fibrillation. Cardiovasc Res 2013 0.77
97 Effects of three metabolites of propiverine on voltage-dependent L-type calcium currents in human atrial myocytes. Eur J Pharmacol 2008 0.77
98 Pharmacological Modulation of Mucosa-Related Impairment of β-Adrenoceptor-Mediated Relaxation in Human Detrusor. Urol Int 2015 0.76
99 Mucosa of human detrusor impairs contraction and β-adrenoceptor-mediated relaxation. BJU Int 2013 0.76
100 The German Competence Network on Atrial Fibrillation (AFNET). Herz 2008 0.76
101 The use of a novel cardiac bioreactor system in investigating fibroblast physiology and its perspectives. Organogenesis 2013 0.76
102 Muscarinic subtype-2 receptor autoantibodies: actors or bystanders in human atrial fibrillation? Eur Heart J 2004 0.75
103 Problem-based learning: a new pathway to competence? Trends Pharmacol Sci 2002 0.75
104 Stroke prevention versus bleeding risk of vitamin-K antagonists: a double-edged sword in patients with atrial fibrillation who require surgery. Cardiovasc Ther 2009 0.75
105 Atrial fibrillation and circulating endothelial progenitor cells. Europace 2010 0.75
106 Erratum: Cardiac RKIP induces a beneficial β-adrenoceptor-dependent positive inotropy. Nat Med 2016 0.75
107 Regulation of cardiac sodium channels by tyrosine kinases - contribution to excitability? J Mol Cell Cardiol 2007 0.75
108 Novel anti-arrhythmic agents for the treatment of atrial fibrillation. Curr Opin Pharmacol 2007 0.75
109 Carvedilol induces greater control of β2- than β 1-adrenoceptor-mediated inotropic and lusitropic effects by PDE3, while PDE4 has no effect in human failing myocardium. Naunyn Schmiedebergs Arch Pharmacol 2014 0.75
110 Do genetics help to better understand the underlying mechanisms of atrial fibrillation? Eur Heart J 2006 0.75
111 Letter by Christ et al regarding article, "Angiotensin II potentiates the slow component of delayed rectifier K+ current via the AT1 receptor in guinea pig atrial myocytes". Circulation 2006 0.75
112 Two centuries of excitation-contraction coupling. Cell Calcium 2004 0.75
113 Do we need new antiarrhythmic compounds in the era of implantable cardiac devices and percutaneous ablation? Cardiovasc Res 2005 0.75
114 Recording atrial monophasic action potentials using standard pacemaker leads: an alternative way to study electrophysiology properties of the human atrium in vivo? Pacing Clin Electrophysiol 2004 0.75
115 [German Competence Network on Atrial Fibrillation (AFNET). A nationwide cooperation for better research and patient care]. Med Klin (Munich) 2006 0.75
116 Changes in morphology and inward rectifier currents in human atrial myocytes depend on culture conditions. Basic Res Cardiol 2002 0.75
117 An interaction between ATP and high K+: mutual impairment of ATP- and high K(+)-evoked [Ca2+]i increase in NG 108-15 cells. Neurochem Res 2002 0.75
118 Muscarinic receptor expression and receptor-mediated detrusor contraction: comparison of juvenile and adult porcine tissue. Pflugers Arch 2007 0.75
119 [Life pictures. Ursula Ravens]. Dtsch Med Wochenschr 2004 0.75
120 Chelerythrine treatment influences the balance of pro- and anti-apoptotic signaling pathways in the remote myocardium after infarction. Mol Cell Biochem 2007 0.75
121 Rate-adaptive pacing using intracardiac impedance shows no evidence for positive feedback during dobutamine stress test. Europace 2002 0.75